Urotronic Inc.
Clinical trials sponsored by Urotronic Inc., explained in plain language.
-
Balloon breakthrough: new hope for blocked ureters?
Disease control Recruiting nowThis study tests a special balloon coated with medication to open narrowed sections of the tube that carries urine from the kidney to the bladder. About 60 adults with a single stricture up to 4 cm long will receive the treatment. The goal is to see if it safely restores urine fl…
Phase: NA • Sponsor: Urotronic Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New catheter device aims to ease bathroom troubles for men with enlarged prostate
Symptom relief Recruiting nowThis study is tracking 500 men who receive the Optilume BPH Catheter System to treat symptoms of an enlarged prostate (BPH). The goal is to see how well the device improves urinary symptoms and how safe it is in everyday use. Participants are followed for 12 months to measure cha…
Sponsor: Urotronic Inc. • Aim: Symptom relief
Last updated May 17, 2026 06:36 UTC
-
New catheter aims to help men with enlarged prostate urinate easier
Symptom relief Recruiting nowThis study tests the Optilume BPH Catheter System in 92 men aged 50 and older with an enlarged prostate causing urinary problems. The goal is to see if the device safely improves symptoms like frequent urination and weak stream. Participants will be followed for 12 months to meas…
Phase: NA • Sponsor: Urotronic Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Balloon treatment for narrowed urethra under sperm safety review
Symptom relief Recruiting nowThis study looks at how a device called Optilume, used to treat a narrowed urethra, affects sperm quality in men aged 22 to 65. Researchers will measure changes in sperm count over 3 and 6 months. The goal is to make sure the treatment does not harm fertility.
Phase: PHASE4 • Sponsor: Urotronic Inc. • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC